Glioblastoma Awareness Day

The House of Representatives recently passed a resolution to designate July 16, 2025, as Glioblastoma Awareness Day.

More than 13,000 Americans are estimated to be diagnosed with glioblastoma in 2025. The disease is the most common malignant brain tumor and accounts for approximately half of all primary malignant brain tumors.

Glioblastoma is described as a disease that affects the 'essence of self', making treatment and removal even more challenging due to the uniquely complex and fragile nature of the brain.

Key Facts About Glioblastoma

• Estimated number of Americans diagnosed with glioblastoma in 2025: over 13,000
• Estimated annual deaths from glioblastoma in the US: over 10,000
• Five-year survival rate for glioblastoma patients: only 6.9 percent
• Median length of survival for glioblastoma patients: only 8 months

Glioblastoma is a devastating disease that requires continued awareness and research efforts.

"Glioblastoma is a complex and aggressive cancer that affects the brain, which makes treatment challenging," said [Name]. "It's essential to continue researching new treatments and improving our understanding of this disease."

What Can We Do?

• Support efforts to develop better treatments for glioblastoma
• Recognize the importance of molecular biomarker testing
• Urges a collaborative approach to brain tumor research among governmental, private, and nonprofit organizations
• Encourages continued investments in glioblastoma research and treatments

Glioblastoma Awareness Day is an opportunity to come together and make a difference.

"By raising awareness about glioblastoma, we can help find new treatments and improve the lives of those affected by this disease," said [Name]. "Let's work together to make a positive impact."